Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 32 studies | 58% ± 22% | |
smooth muscle cell | 29 studies | 48% ± 20% | |
fibroblast | 24 studies | 40% ± 18% | |
astrocyte | 22 studies | 65% ± 24% | |
endothelial cell | 22 studies | 33% ± 17% | |
oligodendrocyte precursor cell | 16 studies | 46% ± 17% | |
glutamatergic neuron | 13 studies | 65% ± 17% | |
connective tissue cell | 13 studies | 41% ± 19% | |
mesothelial cell | 12 studies | 57% ± 17% | |
microglial cell | 10 studies | 32% ± 17% | |
GABAergic neuron | 9 studies | 55% ± 12% | |
neuron | 9 studies | 48% ± 16% | |
retinal cone cell | 9 studies | 68% ± 17% | |
retinal rod cell | 9 studies | 63% ± 16% | |
vein endothelial cell | 9 studies | 46% ± 24% | |
interneuron | 8 studies | 53% ± 16% | |
oligodendrocyte | 8 studies | 26% ± 11% | |
amacrine cell | 8 studies | 58% ± 18% | |
retinal ganglion cell | 7 studies | 70% ± 23% | |
enteroendocrine cell | 6 studies | 62% ± 25% | |
myofibroblast cell | 5 studies | 39% ± 19% | |
progenitor cell | 5 studies | 31% ± 11% | |
retinal bipolar neuron | 5 studies | 69% ± 15% | |
epithelial cell | 5 studies | 29% ± 9% | |
OFF-bipolar cell | 5 studies | 78% ± 8% | |
ON-bipolar cell | 5 studies | 76% ± 9% | |
retina horizontal cell | 5 studies | 41% ± 16% | |
pancreatic A cell | 4 studies | 94% ± 6% | |
type B pancreatic cell | 4 studies | 94% ± 3% | |
granule cell | 4 studies | 58% ± 18% | |
GABAergic amacrine cell | 4 studies | 65% ± 15% | |
glycinergic amacrine cell | 4 studies | 59% ± 8% | |
neuroendocrine cell | 4 studies | 88% ± 6% | |
adventitial cell | 4 studies | 47% ± 16% | |
Mueller cell | 4 studies | 63% ± 7% | |
myoepithelial cell | 4 studies | 51% ± 22% | |
luminal cell of prostate epithelium | 4 studies | 58% ± 8% | |
pancreatic D cell | 3 studies | 96% ± 3% | |
macrophage | 3 studies | 39% ± 16% | |
abnormal cell | 3 studies | 41% ± 12% | |
GABAergic interneuron | 3 studies | 34% ± 7% | |
endothelial cell of vascular tree | 3 studies | 35% ± 14% | |
retinal pigment epithelial cell | 3 studies | 28% ± 9% | |
rod bipolar cell | 3 studies | 86% ± 1% | |
chondrocyte | 3 studies | 47% ± 27% | |
basal cell | 3 studies | 24% ± 6% | |
endothelial cell of artery | 3 studies | 25% ± 4% | |
muscle cell | 3 studies | 47% ± 2% | |
ependymal cell | 3 studies | 50% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 61380.88 | 2627 / 2642 | 100% | 1478.06 | 703 / 705 |
thymus | 98% | 15112.45 | 637 / 653 | 89% | 462.55 | 537 / 605 |
prostate | 87% | 17009.50 | 213 / 245 | 98% | 631.39 | 490 / 502 |
breast | 80% | 8461.23 | 367 / 459 | 56% | 122.48 | 630 / 1118 |
adrenal gland | 48% | 4218.21 | 124 / 258 | 70% | 765.48 | 160 / 230 |
blood vessel | 100% | 43228.33 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 95% | 14083.33 | 1146 / 1204 | 0% | 0 | 0 / 0 |
uterus | 66% | 6762.47 | 112 / 170 | 26% | 61.21 | 121 / 459 |
pancreas | 23% | 2015.19 | 74 / 328 | 66% | 343.35 | 118 / 178 |
kidney | 15% | 1312.94 | 13 / 89 | 59% | 208.21 | 534 / 901 |
esophagus | 53% | 5705.90 | 769 / 1445 | 13% | 23.54 | 23 / 183 |
ovary | 31% | 3606.39 | 56 / 180 | 30% | 47.14 | 127 / 430 |
lung | 20% | 1594.17 | 117 / 578 | 37% | 97.09 | 429 / 1155 |
stomach | 30% | 3288.01 | 108 / 359 | 13% | 24.45 | 38 / 286 |
heart | 43% | 3969.47 | 372 / 861 | 0% | 0 | 0 / 0 |
intestine | 22% | 1691.75 | 209 / 966 | 13% | 27.45 | 67 / 527 |
tonsil | 0% | 0 | 0 / 0 | 31% | 98.17 | 14 / 45 |
bladder | 19% | 1406.76 | 4 / 21 | 12% | 28.50 | 58 / 504 |
skin | 23% | 1969.51 | 414 / 1809 | 7% | 18.75 | 35 / 472 |
liver | 1% | 80.81 | 2 / 226 | 19% | 34.71 | 79 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 6.18 | 2 / 80 |
muscle | 2% | 172.36 | 19 / 803 | 0% | 0 | 0 / 0 |
spleen | 0% | 24.01 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033366 | Biological process | protein localization to secretory granule |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0016485 | Biological process | protein processing |
GO_0003214 | Biological process | cardiac left ventricle morphogenesis |
GO_0036211 | Biological process | protein modification process |
GO_0030072 | Biological process | peptide hormone secretion |
GO_0006518 | Biological process | peptide metabolic process |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0030070 | Biological process | insulin processing |
GO_0072657 | Biological process | protein localization to membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030658 | Cellular component | transport vesicle membrane |
GO_0004181 | Molecular function | metallocarboxypeptidase activity |
GO_0042043 | Molecular function | neurexin family protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0004180 | Molecular function | carboxypeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CPE |
Protein name | Carbocypeptidase E (Carboxypeptidase E, isoform CRA_b) Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase) Carboxypeptidase E |
Synonyms | hCG_15254 |
Description | FUNCTION: Sorting receptor that directs prohormones to the regulated secretory pathway. Acts also as a prohormone processing enzyme in neuro/endocrine cells, removing dibasic residues from the C-terminal end of peptide hormone precursors after initial endoprotease cleavage. . |
Accessions | ENST00000431967.5 D6R930 P16870 C9JE88 ENST00000511992.1 ENST00000513982.5 A0A7S9TQK2 D6RF88 ENST00000402744.9 [P16870-1] |